Hyloris Pharmaceuticals SA (EBR:HYL)
5.88
+0.02 (0.34%)
Oct 29, 2025, 4:52 PM CET
Hyloris Pharmaceuticals Revenue
Hyloris Pharmaceuticals had revenue of 3.34M EUR in the half year ending June 30, 2025, with 74.54% growth. This brings the company's revenue in the last twelve months to 8.46M, up 30.42% year-over-year. In the year 2024, Hyloris Pharmaceuticals had annual revenue of 9.76M with 159.64% growth.
Revenue (ttm)
8.46M
Revenue Growth
+30.42%
P/S Ratio
19.40
Revenue / Employee
169.18K
Employees
49
Market Cap
164.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.76M | 6.00M | 159.64% |
| Dec 31, 2023 | 3.76M | 1.37M | 57.48% |
| Dec 31, 2022 | 2.39M | -709.00K | -22.90% |
| Dec 31, 2021 | 3.10M | 2.92M | 1,669.14% |
| Dec 31, 2020 | 175.00K | 84.00K | 92.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 6.85B |
| argenx SE | 2.66B |
| Fagron NV | 918.75M |
| Ion Beam Applications | 585.76M |
| European Medical Solutions | 49.47M |
| Biocartis Group NV | 47.69M |
| Nyxoah | 4.93M |
| Onward Medical | 2.72M |